Natalie J Shiff

12PUBLICATIONS
80CO-AUTHORS
PharmacogenomicsClinical neuropsychologyDevelopment cooperationHealth psychologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 02, 2024
Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors.

Philip J Mease, Shannon A Ferrante, Natalie J Shiff

|Feb 22, 2024
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis.

Jeffrey R Curtis, Iain B McInnes, Proton Rahman

|Oct 18, 2023
A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.

Kelly Nguyen, Julie Barsalou, Daniah Basodan

|Aug 19, 2023
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Philip J Mease, Alexis Ogdie, John Tesser

|Jun 15, 2023
Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study.

Atul Deodhar, Natalie J Shiff, Cinty Gong

|Jun 15, 2022
Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry.

Natalie J Shiff, Peter Shrader, Colleen K Correll

Pageof 2

Frequent Collaborators

3 joint publications

Soumya D Chakravarty

3 joint publications

Brian M Feldman

3 joint publications

Philip J Mease

2 joint publications

Roberta A Berard